MDX-1100 (anti-CXCL10 human monoclonal antibody) ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
97潰瘍性大腸炎5

97. 潰瘍性大腸炎


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2007-002544-25-CZ
(EUCTR)
21/10/200807/01/2008A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Subjects with Active Ulcerative ColitisA Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Subjects with Active Ulcerative Colitis Active Ulcerative Colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: MDX-1100
Product Code: MDX-1100
Bristol-Myers Squibb International CorporationNULLNot RecruitingFemale: yes
Male: yes
106Phase 2Hungary;Czech Republic;Latvia
2EUCTR2007-002544-25-LV
(EUCTR)
29/05/200818/02/2008A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Subjects with Active Ulcerative ColitisA Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Subjects with Active Ulcerative Colitis Active Ulcerative Colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: MDX-1100
Product Code: MDX-1100
Bristol-Myers Squibb CompanyNULLNot RecruitingFemale: yes
Male: yes
106Phase 2Hungary;Czech Republic;Latvia
3EUCTR2007-002544-25-HU
(EUCTR)
23/05/200807/01/2008A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Subjects with Active Ulcerative ColitisA Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Subjects with Active Ulcerative Colitis Active Ulcerative Colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: MDX-1100
Product Code: MDX-1100
Bristol-Myers Squibb International CorporationNULLNot RecruitingFemale: yes
Male: yes
106Phase 2Hungary;Czech Republic;Latvia
4NCT00656890
(ClinicalTrials.gov)
April 20084/4/2008A Study of MDX-1100 in Subjects With Active Ulcerative ColitisA Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative ColitisUlcerative ColitisBiological: sterile saline for injection;Biological: MDX-1100Bristol-Myers SquibbNULLCompleted18 YearsN/ABoth110Phase 2United States;Canada;Czech Republic;Hungary;Latvia;Romania;Russian Federation;Ukraine
5NCT00295282
(ClinicalTrials.gov)
January 200621/2/2006A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative ColitisA Phase I, Multicenter, Dose-escalation Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Patients With Active Ulcerative ColitisUlcerative ColitisDrug: MDX-1100 (anti-CXCL10 human monoclonal antibody)Bristol-Myers SquibbNULLCompleted18 YearsN/ABoth24Phase 1United States